Micra
Device Pacemakers
PDI 00643169711761
General payments
$5,834,366
Research payments
$17,860,249
Through program year 2025, $5,834,366 in general payments and $17,860,249 in research payments were reported against Micra (Pacemakers).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $926,220 | 12,130 |
| 2025 | Research | $20,300 | 4 |
| 2024 | General | $1,100,357 | 14,081 |
| 2024 | Research | $4,637,351 | 1,563 |
| 2023 | General | $1,536,311 | 16,393 |
| 2023 | Research | $3,927,884 | 1,349 |
| 2022 | General | $1,403,365 | 15,064 |
| 2022 | Research | $4,820,373 | 1,834 |
| 2021 | General | $868,112 | 10,334 |
| 2021 | Research | $4,454,340 | 1,521 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 71 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
68,002 general · 6,271 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.